$1.32
-0.0200 (-1.49%)
At Close: Jun 22, 2026
GOVX: Third Quarter 2019 Results and Update
11:00am, Monday, 11'th Nov 2019
OTC:GOVX GeoVax Labs, Inc. (OTC:GOVX) filed its third quarter 2019 10-Q and issued the accompanying press release on November 7, 2019 providing an operational and financial update on the company’s p
GeoVax Reports 2019 Third Quarter Financial Results and Provides Corporate Update
07:05pm, Thursday, 07'th Nov 2019
The Underlying Value of GeoVax, and the Promise of the Technology...A Comprehensive Review of GeoVax's Various Development Programs ATLANTA, GA / ACCESSWIRE / November 7, 2019 / GeoVax Labs, Inc. (OTC
GeoVax Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV
01:00pm, Thursday, 24'th Oct 2019
On October 18, 2019, AGT announced the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for AGT’s lead HIV program, AGT103-T, a lentiviral v
Ketersediaan listrik menjadi penentu pembangunan industri nasional
08:30am, Tuesday, 25'th Jun 2019
Pemerintah saat ini tengah giat-giatnya mendorong pengusaha untuk berinvestasi sebagai upaya memacu pertumbuhan ekonomi, namun untuk mewujudkannya ...
Sign In
Buy GOVX